Item request has been placed!

Item request cannot be made.

Processing Request

Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer (PERSEVERE)

Item request has been placed!

Item request cannot be made.

Processing Request

اقرأ أكثر حفظ في قائمتي

المؤلفون: Genentech, Inc.; Pfizer; Foundation Medicine; Indiana University; Vera Bradley Foundation for Breast Cancer Research
المصدر:
A Phase II Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer (PERSEVERE)

معلومة اضافية
- Contributors:
  Bryan Schneider, MD, Sponsor-Investigator

تعليقات

No Comments.